세계의 인젝션 펜 시장 규모, 점유율, 성장 분석, 유형별, 치료법별, 최종 사용자별, 지역별 - 산업 예측(2024-2031년)

Global Injection Pen Market size was valued at USD 45 billion in 2022 and is poised to grow from USD 48.57 billion in 2023 to USD 89.43 billion by 2031, growing at a CAGR of 7.93% during the forecast period (2024-2031).

The global injection pen market is witnessing substantial growth due to a convergence of factors such as increasing chronic disease prevalence, a focus on patient-centric care, and advancements in healthcare technology. This transformative market, categorized into product type, therapy type, and end use, highlights the significant roles of both disposable and reusable injection pens. Disposable injection pens, praised for their cost-effectiveness and convenience, have seen heightened adoption, particularly in resource-limited settings and emerging economies. Within the therapy-specific segment, insulin pens dominate, influenced by the rising global diabetes rate and the growing elderly population that drives demand for user-friendly insulin delivery systems, notably GLP-1 pens. These devices represent a significant focus for key market players amid a competitive landscape. Moreover, the global injection pen market exhibits varied regional dynamics, with North America leading the charge, thanks to its concentration of healthcare industry leaders and numerous manufacturers expanding their footprint within the region. The United States stands out as a pivotal hub for injection pen production and innovation, further solidifying its role in shaping market trends and addressing the growing demand for efficient injection solutions. With a combination of evolving medical needs and technological progress, the injection pen market is positioned for continued expansion in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Injection Pen market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Injection Pen Market Segmental Analysis

Global Injection Pen Market is segmented by Type, Therapy, End User, and region. Based on Type, the market is segmented into Disposable Injection Pens, and Reusable Injection Pens. Based on Therapy, the market is segmented into Diabetes, Growth Hormone Therapy, Osteoporosis, Fertility, Obesity, and Other Therapies. Based on End User, the market is segmented into Home Care Settings, Hospitals & Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Injection Pen Market

The integration of advanced technologies into drug delivery systems serves as a significant market driver for the global Injection Pen market. Innovations such as electronic dose memory, Bluetooth connectivity for data tracking, and precision dose delivery mechanisms have revolutionized patient experiences and treatment outcomes. These enhancements make injection pens more user-friendly and accessible, fostering greater adoption among patients, caregivers, and healthcare professionals alike. By improving ease of use and ensuring accurate dosing, these technological advancements not only elevate patient satisfaction but also bolster adherence to prescribed therapies, stimulating market growth and establishing injection pens as essential tools in modern healthcare management.

Restraints in the Global Injection Pen Market

One significant market restraint impacting the global injection pen market is the affordability and accessibility challenges in developing regions. Patients in these areas often grapple with the high costs associated with injection pens and related therapies, which can pose a substantial financial burden, especially in regions with lower economic development. Additionally, limited healthcare infrastructure restricts both the availability and distribution of these advanced drug delivery devices, further hindering access for patients who rely on them for chronic disease management. Consequently, these barriers have a pronounced effect on market growth and the overall adoption of injection pens in these underserved populations.

Market Trends of the Global Injection Pen Market

The global injection pen market is witnessing a significant trend towards personalized and connected solutions that enhance patient engagement and medication adherence. As healthcare increasingly embraces digitalization, the incorporation of advanced connectivity features in injection pens allows for real-time monitoring of patient compliance and tracking of administered doses. This transformation is shifting traditional injection pens into smart devices that facilitate remote management of patients, offering insights into their medication routines. Consequently, pharma companies and manufacturers are investing in research and development to create innovative injection pens that leverage data sharing and technology to improve patient outcomes and streamline healthcare delivery.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Technology Analysis
• Supply Chain Analysis
• Trade Analysis
• Value Chain Analysis
• Regulatory Landscape
• Patent Analysis
• Pricing Analysis
• Customer & Buying Criteria Analysis
• Case Study Analysis

Injection Pen Market by Type

• Market Overview
• Disposable Injection Pens
• Reusable Injection Pens

Injection Pen Market by Therapy

• Market Overview
• Diabetes
  • Insulin
  • Glucagon-Like Peptide-1
• Growth Hormone Therapy
• Osteoporosis
• Fertility
• Obesity
• Other Therapies

Injection Pen Market by End User

• Market Overview
• Home Care Settings
• Hospitals & Clinics

Injection Pen Market Size by Region

• Market Overview
• North America
  • US
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Novo Nordisk A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly And Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Owen Mumford (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocon (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wockhardt Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gerresheimer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shaily Engineering Plastics Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SHL Medical AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emperra GmbH E-Health Technologies (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nemera France SAS (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangsu Delfu Medical Device Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Solteam Medical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stevanato Group (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wanhai Medical Instruments Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments